MIRM
Price
$82.39
Change
+$2.43 (+3.04%)
Updated
Oct 15 closing price
Capitalization
5.71B
32 days until earnings call
Intraday BUY SELL Signals
ORKA
Price
$73.87
Change
-$2.81 (-3.66%)
Updated
Oct 15 closing price
Capitalization
5.57B
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MIRM vs ORKA

MIRM vs ORKA Comparison Chart in %
View a ticker or compare two or three
VS
MIRM vs. ORKA commentary
Oct 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIRM is a Hold and ORKA is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for MIRM with price predictions
Oct 15, 2026

MIRM's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for MIRM moved out of oversold territory on October 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 15 similar instances when the indicator left oversold territory. In 14 of the 15 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for MIRM just turned positive on October 12, 2026. Looking at past instances where MIRM's MACD turned positive, the stock continued to rise in 41 of 48 cases over the following month. The odds of a continued upward trend are 85%.

Following a +3.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where MIRM advanced for three days, in 235 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

MIRM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MIRM as a result. In 59 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

The 50-day moving average for MIRM moved below the 200-day moving average on October 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

The Aroon Indicator for MIRM entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 36 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. MIRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (26.596) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (8.842) is also within normal values, averaging (437.542).

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for ORKA with price predictions
Oct 15, 2026

ORKA in downward trend: price dove below 50-day moving average on September 18, 2026

ORKA moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend. In 38 of 48 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ORKA as a result. In 65 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.

The Moving Average Convergence Divergence Histogram (MACD) for ORKA turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 37 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 69%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORKA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

The Aroon Indicator for ORKA entered a downward trend on October 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for ORKA's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +1.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where ORKA advanced for three days, in 203 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

ORKA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.015) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. ORKA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORKA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
MIRM vs ORKA: Fundamental Ratings
MIRM
ORKA
OUTLOOK RATING
1..100
7158
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
39
Fair valued
PROFIT vs RISK RATING
1..100
36100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
6439
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORKA's Valuation (39) in the null industry is in the same range as MIRM (69). This means that ORKA’s stock grew similarly to MIRM’s over the last 12 months.

MIRM's Profit vs Risk Rating (36) in the null industry is somewhat better than the same rating for ORKA (100). This means that MIRM’s stock grew somewhat faster than ORKA’s over the last 12 months.

ORKA's SMR Rating (94) in the null industry is in the same range as MIRM (100). This means that ORKA’s stock grew similarly to MIRM’s over the last 12 months.

ORKA's Price Growth Rating (39) in the null industry is in the same range as MIRM (64). This means that ORKA’s stock grew similarly to MIRM’s over the last 12 months.

ORKA's P/E Growth Rating (100) in the null industry is in the same range as MIRM (100). This means that ORKA’s stock grew similarly to MIRM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MIRMORKA
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 1 day ago
68%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 14 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
64%
Bearish Trend 1 day ago
74%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
60%
Aroon
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
73%
COMPARISON
Comparison
Oct 16, 2026
Stock price -- (MIRM: $82.39 vs. ORKA: $73.87)
Brand notoriety: MIRM and ORKA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MIRM: 84% vs. ORKA: 133%
Market capitalization -- MIRM: $5.71B vs. ORKA: $5.57B
MIRM [@Biotechnology] is valued at $5.71B. ORKA’s [@Biotechnology] market capitalization is $5.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MIRM’s FA Score shows that 0 FA rating(s) are green while ORKA’s FA Score has 0 green FA rating(s).

  • MIRM’s FA Score: 0 green, 5 red.
  • ORKA’s FA Score: 0 green, 5 red.
According to our system of comparison, ORKA is a better buy in the long-term than MIRM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIRM’s TA Score shows that 5 TA indicator(s) are bullish while ORKA’s TA Score has 4 bullish TA indicator(s).

  • MIRM’s TA Score: 5 bullish, 4 bearish.
  • ORKA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MIRM is a better buy in the short-term than ORKA.

Price Growth

MIRM (@Biotechnology) experienced а +1.28% price change this week, while ORKA (@Biotechnology) price change was -4.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.57%. For the same industry, the average monthly price growth was -12.13%, and the average quarterly price growth was -18.10%.

Reported Earning Dates

MIRM is expected to report earnings on Nov 17, 2026.

ORKA is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (-5.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
MIRM
Daily Signal:
Gain/Loss:
ORKA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PALL20.580.75
+3.78%
abrdn Physical Palladium Shares ETF (PALL)
PLTM15.610.26
+1.69%
GraniteShares Platinum Trust (PLTM)
MCHI51.690.25
+0.49%
iShares MSCI China ETF (MCHI)
ARCM100.070.04
+0.03%
Arrow Reserve Capital Management ETF (ARCM)
YFYA9.69-0.01
-0.10%
Yields for You Strategy A ETF

MIRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with XERS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then XERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRM
1D Price
Change %
MIRM100%
+3.04%
XERS - MIRM
45%
Loosely correlated
+3.07%
KURA - MIRM
43%
Loosely correlated
+0.94%
EXEL - MIRM
42%
Loosely correlated
+3.02%
PTCT - MIRM
41%
Loosely correlated
+2.21%
ORKA - MIRM
40%
Loosely correlated
-3.66%
More

ORKA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORKA has been loosely correlated with SYRE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ORKA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORKA
1D Price
Change %
ORKA100%
-3.66%
SYRE - ORKA
51%
Loosely correlated
+1.87%
DNTH - ORKA
43%
Loosely correlated
-0.31%
CGON - ORKA
41%
Loosely correlated
+0.03%
IMVT - ORKA
41%
Loosely correlated
-1.40%
TRVI - ORKA
41%
Loosely correlated
+0.41%
More